Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Bad financial results growth rate -90.0% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (18.3%)
  • Dividend yield for the last twelve months 6.3%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 3.4% higher than minimum and 57.1% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (26.3x vs
    )

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (0.0%)26.265
year average price 32.18  


year start price 39.33 2023-04-25

max close price 40.28 2023-06-13

min close price 25.39 2024-04-18

current price 26.26 2024-04-23
Common stocks: 5 615 000 000

Dividend Yield:  6.3%
EV / LTM EBITDA: 26.3x
Last revenue growth (y/y):  -41.3%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  19.7%
Historical growth of EBITDA:  16.8%
Target EV / EBITDA (hist percentile):
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 147 478
Net Debt ($m): 13 353
EV (Enterprise Value): 160 831
EBITDA LTM ($m): 6 122
EV / LTM EBITDA: 26.3x
Price to Book: 1.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-04-23The Motley Fool

Better Buy: Pfizer vs. Viking Therapeutics

2024-04-22Zacks Investment Research

Pfizer (PFE) Rises Higher Than Market: Key Facts

2024-04-19Zacks Investment Research

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

2024-04-19Seeking Alpha

Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth

2024-04-16Seeking Alpha

Pfizer's Doldrums, Just A Bad Case Of COVID-19?

2024-04-15Zacks Investment Research

Why the Market Dipped But Pfizer (PFE) Gained Today

2024-04-15The Motley Fool

Is Pfizer Stock a Buy?

2024-04-12Seeking Alpha

Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here

2024-04-12The Motley Fool

Is Pfizer Stock the Biggest Bargain in the S&P 500?

2024-04-11Seeking Alpha

Pfizer: The Market Is Wrong
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data